CD133 Enriched Bone Marrow Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD133 Enriched Bone Marrow Cells, covering 2015-04-22 to 2015-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Trial Using CD133 Enriched Bone Marrow Cells Following Primary Angioplasty for Acute Myocardial Infarction [NA]